Valuation: Celltrion, Inc.

Market Cap 42,600B 31.26B 27.08B 25.61B 23.18B 43.51B 2,999B 43.84B 306B 118B 1,521B 117B 115B 4,849B P/E 2026 *
26.9x
P/E 2027 * 23x
Enterprise Value 44.81B 32.89M 28.49M 26.94M 24.39M 45.77M 3.15B 46.12M 321M 124M 1.6B 124M 121M 5.1B EV / Sales 2026 *
8.12x
EV / Sales 2027 * 6.94x
Free-Float
60.59%
Yield 2026 *
0.42%
Yield 2027 * 0.47%
1 day-0.73%
1 week-3.06%
Current month-6.03%
1 month-11.69%
3 months+1.43%
6 months-9.31%
Current year+2.97%
1 week 174,600
Extreme 174600
183,500
1 month 174,600
Extreme 174600
202,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
239,247.57
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Chief Executive Officer 42 2021-03-25
President 51 2026-02-12
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 2005-03-31
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/16/26 Sell 500 0.0002%
1/16/26 Sell 1,000 0.0004%
1/16/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.73%-3.06%+9.63%+38.92% 31.26B
-0.09%-0.45%-2.41%+26.23% 45.81B
-0.12%-1.19%+343.42%+545.03% 43.91B
+1.51%+4.04%+45.01%+27.38% 44.39B
-2.07%-1.42%+4.28%+72.97% 39.4B
-9.49%-11.23% - - 15.75B
+4.21%+5.01%+24.99%+121.62% 17.32B
+0.93%+4.60%+18.45%+34.86% 14.73B
-0.08%-2.81%+79.24%+31.27% 13.03B
+2.08%+8.91%+1.17%-34.11% 13.31B
Average -0.38%-0.19%+58.20%+96.02% 27.89B
Weighted average by Cap. -0.29%-0.75%+72.92%+125.46%

Financials

2026 *2027 *
Net sales 5,518B 4.05B 3.51B 3.32B 3B 5.64B 388B 5.68B 39.58B 15.23B 197B 15.21B 14.87B 628B 6,337B 4.65B 4.03B 3.81B 3.45B 6.47B 446B 6.52B 45.46B 17.49B 226B 17.47B 17.08B 721B
Net income 1,536B 1.13B 976M 923M 836M 1.57B 108B 1.58B 11.01B 4.24B 54.81B 4.23B 4.14B 175B 1,785B 1.31B 1.13B 1.07B 971M 1.82B 126B 1.84B 12.8B 4.93B 63.71B 4.92B 4.81B 203B
Net Debt 2,215B 1.63B 1.41B 1.33B 1.21B 2.26B 156B 2.28B 15.89B 6.11B 79.05B 6.1B 5.97B 252B 1,355B 994M 861M 814M 737M 1.38B 95.38B 1.39B 9.72B 3.74B 48.36B 3.74B 3.65B 154B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
26-09-15 ₩177,500.00 -0.73% 195,823
26-09-14 ₩178,800.00 +0.34% 396,196
26-09-11 ₩178,200.00 -1.44% 564,770
26-09-10 ₩180,800.00 -1.26% 742,053
26-09-09 ₩183,100.00 0.00% 372,393
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
177,500.00KRW
Average target price
268,232.21KRW
Spread / Average Target
+51.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!